MEDICINES RISK COMMUNICATION
This course domain covers the Basics in medicines risk communication, the Information and communication about benefit-risk of medicines. Basic principles., the Key roles and stakeholders in medicines risk communication: duties and challenges and the Case studies in medicines risk communication.
medicines, risk communication
available for this domain
- To know the basic principles of medicines risk communication, its tools and its place in mitigating risk linked to the use of medicines
- To get a clear understanding of the stakes and stakeholders' involvement in medicines risk communication and their determinants
- To have an accurate view of the way medicines risk communication works in the real life
Developed with the Academic expertise of the Università degli Studi della Campania Luigi Vanvitelli.
Developed with the Regulatory expertise of the Agence nationale de sécurité du médicament et des produits de santé.
Developed with the Pharma Industry expertise of Eli Lilly and Company Limited, AstraZeneca AB.
Eu2P COURSE DOMAINS
Confused? Read the FAQs...